Alzheon SAB Member Marwan Sabbagh, MD interview with NeurologyToday, an official publication of the American Academy of Neurology (AAN)
Article In Brief
Investigators review the scientific evidence for targeting amyloid oligomers and outline the case for a new drug in development for Alzheimer’s disease, ALZ-801, an orally administered prodrug of tramiprosate.
Read the full article here